+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Embolism Stockings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 250 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5918330
The global Anti-Embolism Stockings Market, valued at US$ 740 million in 2024, is expected to reach a substantial US$ 1100 million by the end of 2031.

Market Dynamics

Anti-embolism stockings play a vital role in preventing embolisms, which can occur when objects such as blood clots or air bubbles block arteries, potentially leading to serious health consequences. These stockings effectively reduce the cross-sectional area of limbs, increase venous flow velocity, diminish vein wall dilation, and enhance valvular function. Consequently, they counteract hypertension caused by venous issues and reduce the risk of deep vein thrombosis (DVT).

Growth Opportunities

Major market players are actively exploring opportunities to enhance the effectiveness of anti-embolism stockings. Integration of sensors into these stockings is one avenue being pursued to improve their performance. Manufacturers are also focusing on developing non-pneumatic shock-absorbing compression garments as an effective intervention for intradialytic hypotension.

Moreover, there is potential for the use of anti-embolism stockings among cancer patients, particularly for the treatment of venous thromboembolism. Although this segment is not well-defined currently, it appears promising in terms of growth due to its affordability and ease of use.

Challenges and Limitations

Improper usage of anti-embolism stockings can lead to complications and suboptimal medical outcomes, resulting in patient dissatisfaction. Proper application is essential, as incorrect use can cause significant issues, particularly among elderly, malnourished patients, and individuals with thin or fragile skin. Improperly worn stockings can lead to skin cracks, which can impede market growth.

Furthermore, strict manufacturing guidelines are necessary to ensure optimal therapeutic efficacy, product reliability, and patient comfort. Patients with fragile skin, venous ulcers, or other wounds may experience friction and irritation from the garment, limiting design possibilities. Patient safety is paramount, making consistent and repeatable pressure application a significant challenge due to the limited size of most compression garments.

Country-wise Insights

  • United States: The United States is witnessing an increasing demand for anti-embolism stockings due to a growing geriatric population and rising prevalence of blood-related diseases. The surge in online sales of these stockings also presents additional growth opportunities.
  • United Kingdom: Increased awareness of health and advancements in orthopedic technologies have contributed to the rising adoption of anti-embolism stockings in the UK. Online advertising highlighting their effectiveness in treating venous disease has played a significant role in shifting consumer preferences towards anti-embolism stockings.
  • India: India is emerging as a lucrative market for anti-embolism stockings, driven by the increasing prevalence of deep vein thrombosis (DVT) and other blood clotting disorders. The combination of a large population and rising health concerns positions India as an attractive market for manufacturers in this segment.

Competitive Landscape

The anti-embolism stockings market is marked by a high degree of fragmentation due to numerous competitors. Key players are adopting various strategies to maintain their market position. These strategies include expanding into emerging regions, developing innovative products, and enhancing online advertising and sales channels to strengthen their market presence.

Key Companies Profiled

  • Medtronic (Covidien)
  • Sigvaris
  • Medi
  • BSN Medical
  • Juzo
  • 3M
  • Bauerfeind AG
  • Thuasne Corporate
  • Pretty Legs Hosiery
  • Salzmann-Group
  • Paul Hartmann
  • Cizeta Medicali
  • Belsana Medical
  • Gloria Med
  • Zhende Medical Group
  • Maizi
  • TOKO
  • Okamoto Corporation
  • Zhejiang Sameri
  • MD

Anti-Embolism Stockings Industry Research Segmentation

By Product:

  • Calf-length
  • Thigh-length

By Demography:

  • Men
  • Women

By End User:

  • Ambulatory Patients
  • Post-operative Patients
  • Pregnant Women
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Anti-Embolism Stockings Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 - 2023
3.1. Global Anti-Embolism Stockings Market Production Output, by Region, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Product/ Material, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Anti-Embolism Stockings Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Anti-Embolism Stockings Market Outlook, 2018 - 2031
5.1. Global Anti-Embolism Stockings Market Outlook, by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Calf-length
5.1.1.2. Thigh-length
5.2. Global Anti-Embolism Stockings Market Outlook, by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Men
5.2.1.2. Women
5.3. Global Anti-Embolism Stockings Market Outlook, by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Ambulatory Patients
5.3.1.2. Post-operative Patients
5.3.1.3. Pregnant Women
5.3.1.4. Others
5.4. Global Anti-Embolism Stockings Market Outlook, by Region, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Anti-Embolism Stockings Market Outlook, 2018 - 2031
6.1. North America Anti-Embolism Stockings Market Outlook, by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Calf-length
6.1.1.2. Thigh-length
6.2. North America Anti-Embolism Stockings Market Outlook, by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Men
6.2.1.2. Women
6.3. North America Anti-Embolism Stockings Market Outlook, by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Ambulatory Patients
6.3.1.2. Post-operative Patients
6.3.1.3. Pregnant Women
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Anti-Embolism Stockings Market Outlook, by Country, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. U.S. Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.4.1.2. U.S. Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.4.1.3. U.S. Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.4.1.4. Canada Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.4.1.5. Canada Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.4.1.6. Canada Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Anti-Embolism Stockings Market Outlook, 2018 - 2031
7.1. Europe Anti-Embolism Stockings Market Outlook, by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Calf-length
7.1.1.2. Thigh-length
7.2. Europe Anti-Embolism Stockings Market Outlook, by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Men
7.2.1.2. Women
7.3. Europe Anti-Embolism Stockings Market Outlook, by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Ambulatory Patients
7.3.1.2. Post-operative Patients
7.3.1.3. Pregnant Women
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Anti-Embolism Stockings Market Outlook, by Country, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Germany Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.2. Germany Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.3. Germany Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.4. U.K. Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.5. U.K. Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.6. U.K. Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.7. France Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.8. France Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.9. France Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.10. Italy Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.11. Italy Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.12. Italy Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.13. Turkey Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.14. Turkey Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.15. Turkey Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.16. Russia Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.17. Russia Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.18. Russia Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.19. Rest of Europe Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.20. Rest of Europe Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.1.21. Rest of Europe Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Anti-Embolism Stockings Market Outlook, 2018 - 2031
8.1. Asia Pacific Anti-Embolism Stockings Market Outlook, by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Calf-length
8.1.1.2. Thigh-length
8.2. Asia Pacific Anti-Embolism Stockings Market Outlook, by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Men
8.2.1.2. Women
8.3. Asia Pacific Anti-Embolism Stockings Market Outlook, by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Ambulatory Patients
8.3.1.2. Post-operative Patients
8.3.1.3. Pregnant Women
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Anti-Embolism Stockings Market Outlook, by Country, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. China Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.2. China Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.3. China Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.4. Japan Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.5. Japan Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.6. Japan Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.7. South Korea Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.8. South Korea Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.9. South Korea Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.10. India Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.11. India Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.12. India Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.13. Southeast Asia Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.14. Southeast Asia Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.15. Southeast Asia Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.16. Rest of Asia Pacific Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.17. Rest of Asia Pacific Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.1.18. Rest of Asia Pacific Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Anti-Embolism Stockings Market Outlook, 2018 - 2031
9.1. Latin America Anti-Embolism Stockings Market Outlook, by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Calf-length
9.1.1.2. Thigh-length
9.2. Latin America Anti-Embolism Stockings Market Outlook, by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.2.1.1. Men
9.2.1.2. Women
9.3. Latin America Anti-Embolism Stockings Market Outlook, by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Ambulatory Patients
9.3.1.2. Post-operative Patients
9.3.1.3. Pregnant Women
9.3.1.4. Others
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Anti-Embolism Stockings Market Outlook, by Country, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Brazil Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.2. Brazil Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.3. Brazil Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.4. Mexico Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.5. Mexico Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.6. Mexico Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.7. Argentina Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.8. Argentina Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.9. Argentina Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.10. Rest of Latin America Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.11. Rest of Latin America Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.1.12. Rest of Latin America Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Anti-Embolism Stockings Market Outlook, 2018 - 2031
10.1. Middle East & Africa Anti-Embolism Stockings Market Outlook, by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Calf-length
10.1.1.2. Thigh-length
10.2. Middle East & Africa Anti-Embolism Stockings Market Outlook, by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Men
10.2.1.2. Women
10.3. Middle East & Africa Anti-Embolism Stockings Market Outlook, by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Ambulatory Patients
10.3.1.2. Post-operative Patients
10.3.1.3. Pregnant Women
10.3.1.4. Others
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Anti-Embolism Stockings Market Outlook, by Country, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. GCC Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.2. GCC Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.3. GCC Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.4. South Africa Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.5. South Africa Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.6. South Africa Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.7. Egypt Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.8. Egypt Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.9. Egypt Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.10. Nigeria Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.11. Nigeria Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.12. Nigeria Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.13. Rest of Middle East & Africa Anti-Embolism Stockings Market by Product, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.14. Rest of Middle East & Africa Anti-Embolism Stockings Market by Demography, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.1.15. Rest of Middle East & Africa Anti-Embolism Stockings Market by End User, Value (US$ Mn) and Volume (‘000 Units), 2018 - 2031
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. By End User vs by Demography Heat map
11.2. Manufacturer vs by Demography Heatmap
11.3. Company Market Share Analysis, 2023
11.4. Competitive Dashboard
11.5. Company Profiles
11.5.1. Medtronic (Covidien)
11.5.1.1. Company Overview
11.5.1.2. Product Portfolio
11.5.1.3. Financial Overview
11.5.1.4. Business Strategies and Development
11.5.2. Sigvaris
11.5.2.1. Company Overview
11.5.2.2. Product Portfolio
11.5.2.3. Financial Overview
11.5.2.4. Business Strategies and Development
11.5.3. Medi
11.5.3.1. Company Overview
11.5.3.2. Product Portfolio
11.5.3.3. Financial Overview
11.5.3.4. Business Strategies and Development
11.5.4. BSN Medical
11.5.4.1. Company Overview
11.5.4.2. Product Portfolio
11.5.4.3. Financial Overview
11.5.4.4. Business Strategies and Development
11.5.5. Juzo
11.5.5.1. Company Overview
11.5.5.2. Product Portfolio
11.5.5.3. Financial Overview
11.5.5.4. Business Strategies and Development
11.5.6. 3M
11.5.6.1. Company Overview
11.5.6.2. Product Portfolio
11.5.6.3. Financial Overview
11.5.6.4. Business Strategies and Development
11.5.7. Bauerfeind AG
11.5.7.1. Company Overview
11.5.7.2. Product Portfolio
11.5.7.3. Financial Overview
11.5.7.4. Business Strategies and Development
11.5.8. Thuasne Corporate
11.5.8.1. Company Overview
11.5.8.2. Product Portfolio
11.5.8.3. Financial Overview
11.5.8.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

  • MD
  • Medtronic(Covidien)
  • Sigvaris, Medi
  • BSN Medical
  • Juzo
  • 3M
  • Bauerfeind AG
  • Thuasne Corporate
  • Pretty Legs Hosiery
  • Salzmann-Group
  • Paul Hartmann
  • Cizeta Medicali
  • Belsana Medical
  • Gloria Med
  • Zhende Medical Group
  • Maizi
  • TOKO
  • Okamoto Corporation
  • Zhejiang Sameri

Methodology

Loading
LOADING...